Inventor

GUOSEN YE

Inventor

Overview

4→

Patents

2022–2026

Patent span

Human necessities

Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%

C07DHeterocyclic compounds27%

A61KPreparations for medical, dental or toiletry purposes20%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium13%

C07KPeptides7%

Y02ATechnologies for adaptation to climate change7%

PatentTitleYear

12,521,393Cytotoxicity targeting chimeras for CCR2-expressing cells2026 11,976,057MrgX2 antagonists2024 11,970,480Heterocyclic amides useful as protein modulators2024 11,229,623TRPV4 antagonists2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022Patents assigned to GLAXOSMITHKLINE IP NO 2 LTD (1)· patent assignee history

2022–2026Based in US· patent location history

2024–2026Patents assigned to GLAXOSMITHKLINE IP DEV LTD (3)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
GLAXOSMITHKLINE IP DEV LTD	3	2024–2026
GLAXOSMITHKLINE IP NO 2 LTD	1	2022

Locations

Location	Patents	Span
US	4	2022–2026